Mulmit

Hepion Pharmaceuticals, Inc.Hepion Pharmaceuticals, Inc.

HEPA OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2023-12-310-48,447,954-48,926,042-616.07
2022-12-310-45,488,726-42,200,049-11.9
2021-12-310-30,403,309-32,722,168-0.47
2020-12-310-20,146,075-20,353,938-2.1

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-19Stetz Gary S.Interim CEO1,345,500
2026-08-19LoPriore Vincent SExecutive Chairman1,345,500
2026-08-19LoPriore ChaseVP, Corp. Dev.1,345,500
2026-08-19Fisher Danina299,000
2026-08-19Liddy James Gordon299,000
2026-08-19Appajosyula SireeshChief Operating Officer1,345,500
2026-08-19Stetz Gary S. II299,000
2026-08-03Stetz Gary S. II500,000
2026-08-03Stetz Gary S. II500,000
2026-08-03Stetz Gary S.Interim CEO2,000,000
2026-08-03Stetz Gary S.Interim CEO2,000,000
2026-08-03Purcell Michael J.2,000,000

8-K events

FiledItems
2026-08-27Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-08-20Officer or director change
2026-08-04Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-07-02Officer or director change
2026-06-17Submission of matters to a vote
2026-04-22Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-04-14Entry into a material agreement · Officer or director change
2026-03-18Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…